Chris Markoch

Chris Markoch

Chris Markoch is a freelance financial writer who brings over 25 years in sales and marketing to help find the story behind the stock. Chris starts by asking the question, “So what?” and then uses fundamental and (some) technical analysis to add depth to that insight.

Stepping back from the “what” allows Chris to bring perspective that helps investors make wise decisions based on their risk tolerance and investing timeline.

Markoch would describe his writing as being for investors more than traders. He looks at equities through a long-term lens and that is reflected in his writing.

In addition to his articles on InvestorPlace, you can also find Chris’ writing on MarketBeat.com where he has collaborated on the e-book “5 Investing Trends That Will Define the Market in 2022.” You can find Chris on LinkedIn and on Twitter.

Recent Articles

Will Uncle Sam Come to the Rescue of F Stock Again?

In a desperate situation as the coronavirus wipes out automobile sales, F stock needs a government bailout. But even then, Ford is a tough investment to justify.

3 Top Value Stocks for Long-Term Investors

Buying on the dip is a tried-and-true investment strategy, but the best value stocks show their strength over the long term.

Look at American Airlines Stock Through a Wider Lens

Every airline stock is being punished by the coronavirus pandemic. But AAL stock was not as healthy as other airline stocks before the virus.

Is It Time to Change the Conversation About TSLA Stock?

A "new normal" doesn't just apply to societal behaviors. Instead, it could also impact the bullish case for TSLA stock.

Buying INO Stock Right Now Is More a Bet Than an Investment

Ino stock has brought its COVID-19 vaccine to trial in record time. But for the stock to move higher, it needs to get the product to market.